Author:
Eyuboglu Mehmet,Karakoyun Suleyman,Kucuk Ugur
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging
Reference4 articles.
1. Alparslan B, Nas OF, Eritmen UT, Duran S, Ozkaya G, Hakyemez B. The effect of stent cell geometry on carotid stenting outcomes. Cardiovasc Intervent Radiol. 2015. doi: 10.1007/s00270-015-1211-3 .
2. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, Collet JP, Cremonesi A, De Carlo M, Erbel R, Fowkes FG, Heras M, Kownator S, Minar E, Ostergren J, Poldermans D, Riambau V, Roffi M, Röther J, Sievert H, van Sambeek M, Zeller T, ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851–906.
3. Miyazaki Y, Mori T, Iwata T, Aoyagi Y, Tanno Y, Kasakura S, Yoshioka K. Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions. J Neurointerv Surg. 2015. doi: 10.1136/neurintsurg-2014-011565 .
4. Suzuki H, Sano T, Umeda Y, Yamamoto A, Toma N, Sakaida H, Taki W. Valsartan prevents neointimal hyperplasia after carotid artery stenting by suppressing endothelial cell injuries. Neurol Res. 2015;37:35–42.